Login Register Cart 0
Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Shwasananda Vati, a South Indian Traditional Herbo-Mineral Formulation: Insights on the Proposed Biological Roles, Safety, and Therapeutic Profile

Author(s): Shrilata, Sanath Kumar T.*, Dileep Kumar and Rohit Sharma*

Volume 9, Issue 3, 2023

Published on: 04 August, 2022

Article ID: e200522205048 Pages: 15

DOI: 10.2174/2215083808666220520091725

Price: $65

Abstract

Shwasananda vati (SV) is a South Indian traditional herbo-mineral formulation widely used in different parts of southern India, particularly in Kerala state. The formulation is documented in an ancient Kerala traditional treatise and is widely used as a treatment for respiratory ailments in both children and adults. The formulation is cited in an ancient Kerala traditional treatises and significantly used as a remedy for respiratory ailments in children as well as adults. The composition comprises herbs and mineral which is categorized under poisonous drugs (schedule E (1) drugs) as per Ayurvedic Indian traditional system of medicine. However, in Ayurveda, herbo-mineral drugs are purified or detoxified before being used for therapeutic purposes. Ayurveda doctrines consider these herbo-mineral medications to have unique attributes such as instant effectiveness, the requirement of a very small dosage, and a wide range of therapeutic utility. The compliance data on the safety and efficacy of this formulation or its ingredients is scarce. To place traditional medicine on a scientific footing, a thorough knowledge of SV, its therapeutic potential, safety, and toxicity profile, supported by scientific evidence, is necessary. The present report analyses the role of this traditional preparation, highlighting traditional therapeutic claims, possible bioactivities, safety profile, and therapeutic potential as per current assumptions of science.

Keywords: Shwasananda vati (SV) is a South Indian traditional herbo-mineral formulation widely used in different parts of southern India, particularly in Kerala state. The formulation is documented in an ancient Kerala traditional treatise and is widely used as a treatment for respiratory ailments in both children and adults. The formulation is cited in an ancient Kerala traditional treatises and significantly used as a remedy for respiratory ailments in children as well as adults. The composition comprises herbs and mineral which is categorized under poisonous drugs (schedule E (1) drugs) as per Ayurvedic Indian traditional syst, in Ayurveda, herbo-mineral drugs are purified or detoxified before being used for therapeutic purposes. Ayurveda doctrines consider these herbo-mineral medications to have unique attributes such as instant effectiveness, the requirement of a very small dosage, and a wide range of therapeutic utility. The compliance data on the safety and efficacy of this formulation or its ingredients is scarce. To place traditional medicine on a scientific footing, a thorough knowledge of SV, its therapeutic potential, safety, and toxicity profile, supported by scientific evidence, is necessary. The present report analyses the role of this traditional preparation, highlighting traditional therapeutic claims, possible bioactivities, safety profile, and therapeutic potential as per current assumptions of science.

Graphical Abstract

[1]
Kaikulangara R, Druma AK. 1st Ed. Thrissur: Sahithi Books 2001; pp. 70-85.
[2]
Malik V. Drugs and Cosmetics Act, 1940. 18th ed. Lucknow: Eastern Book Company 2005; p. 351.
[3]
Prajapati PK, Sarkar PK, Nayak SV, Joshi RD, Ravishankar B. Safety and toxicity profile of some metallic preparations of ayurveda. Anc Sci Life 2006; 25(3-4): 57-63.
[PMID: 22557208]
[4]
Rastogi S, Rastogi R, Singh RH. Adverse effects of Ayurvedic drugs: An overview of causes and possibilities in reference to a case of Vatsanabha (Aconite) overdosing. Int J Risk Saf Med 2007; 19: 117-256.
[5]
Sharma R, Prajapati PK. Pharmaceutico-therapeutic vistas of Kasisa (green vitriol) in Ayurveda. Int J Advanced Ayurveda Pharm Res 2016; 2: 1.
[6]
Remya A, Divya R, Mishra AK, et al. Standardization of the preparation of a herbo-mineral formulation Swasananda Gulika. IAMJ 2017; 5(9): 3579-89.
[7]
Anonymous. The Ayurvedic Pharmacopoeia of India. 1st Ed. New Delhi: Ministry of Health and Family Welfare, Govt of India 2003; 1: p. 494.
[8]
Sapkota YR, Patgiri BJ, Shukla VS, Prajapati PP. An impact of modern analytical tools in the standardization of Kharaliya Rasayana (Arogyavardhini rasa): The standardization of kharaliya rasayana (Arogyavardhini rasa). J Ayurveda Campus 2021; 2(1): 12-8.
[9]
Sugeena P, Tharalakshmi S. Cytotoxicity evaluation of Swasanandam gutika by MTT assay in mouse fibroblast cells. Int J Health Sci Res 2020; 10(6): 30-5.
[10]
Asma P, Krishna MG, Shashidhar J. A conceptual review on Hingula (Cinnabar-HgS). Int J Ayurveda Pharma Res 2019; 7(6): 32-9.
[11]
Singh TR, Bedarkar P, Patgiri B, Parhate S. Extraction of parad from Hingula, a traditional ayurvedic method. World J Pharm Res 2018; 7(5): 1026-32.
[12]
Mehta NJ, Patgiri BJ, Prajapati PK. Standard operating procedure of Hingulottha Parada. Int J Ayurvedic Med 2010; 2: 27-36.
[13]
Prabhakar IM, Ranjan PR. Preperation and phisicochemical characterisation of Hingula Manikya Rasa. Int J Res Ayurveda Pharm 2013; 4: 847-50.
[http://dx.doi.org/10.7897/2277-4343.04613]
[14]
Kannal NV, Patil MC, Nidagundi SP. Pharmaceutico-analytical study of Haragouri Rasa. J Ayurveda Integr Med Sci 2018; 3(4): 85-90.
[15]
Kumar V. Standard manufacturing procedure of Malla Sindura. Int J Green 2016; 10(4): 235-42.
[16]
Nithya VS. A review on need of Vatsanabha (Aconitum ferox) Shodhana and its Pharmacovigilance concern. J Pharmacovigil Drug Saf 2019; 16(2): 45-6.
[17]
Sarkar PK, Prajapati PK, Pillai APG, Chauhan MG. Pharmacognosy of aconite sold under the name Vatsanabha in Indian market. Indian J Tradit Knowl 2012; 11(4): 685-96.
[18]
Bhattacharya IC. A Note on Aconitum chasmanthus Stapf. Ex Holmes. Indian J Pharm 1961; 23(10): 276-8.
[19]
Buha M, Sojitra N, Acharya R. Internal applications of Vatsanabha (Aconitum ferox wall.): A comprehensive Ayurvedic review. Ayurpharm Int J Ayur Alli Sci 2018; 7(2): 15-38.
[20]
Paolo Z. Camphor: Risks and benefits of a widely used natural product. J Appl Sci Environ Manag 2009; 13(2): 6974.
[21]
Garg N, Jain A. Therapeutic and medicinal uses of Karpura-A review. Int J Sci Res 2017; 6(4): 1174-81.
[22]
Standardisation of ayurvedic tailas hepsibah p.T.a, and rosamma m.p drug standardization unit: Ayurveda research institute poojappura, thiruvananthapuram - 695 012, India. Anc Sci Life 1999; 18(3-4): 275-8.
[23]
Sreeja R, Vineeth PK, Ramesh NV. A case series study on the effect of Eranda taila and karpoora paste in management of gingivitis. IJAHM 2019; 9(5): 3625-8.
[24]
Shukla VR, Wali AA, Dongargaon TN. A randomized controlled trial to evaluate the efficacy of Karpura ghrita as a topical analgesic with lignocaine jelly 2% in posthemorrhoidectomy pain. Indian J Health Sci Biomed Res 2018; 11(1): 60.
[http://dx.doi.org/10.4103/kleuhsj.kleuhsj_127_17]
[25]
Yadav R, Shayan M, Vikram S. Censorious appraisal of Malahara Kalpana. J Ayurveda Integr Med Sci 2021; 6(02): 148-62.
[26]
Anonymous . Gulika yogangal. In: Sahasra YP, Pillai G, Eds. Alappuzha. Vidyarambam Publishers 2006; p. 139.
[27]
Chouhan B, Kumawat RC, Kotecha M, Ramamurthy A, Nathani S. Myrobalans: A comprehensive ayurvedic review. Int J Res Ayurveda Pharm 2013; 4(4): 612-7.
[http://dx.doi.org/10.7897/2277-4343.04433]
[28]
Baliga MS, Meera S, Mathai B, Rai MP, Pawar V, Palatty PL. Scientific validation of the ethnomedicinal properties of the Ayurvedic drug Triphala: A review. Chin J Integr Med 2012; 18(12): 946-54.
[http://dx.doi.org/10.1007/s11655-012-1299-x] [PMID: 23239004]
[29]
Parveen R, Shamsi TN, Singh G, Athar T, Fatima S. Phytochemical analysis and in-vitro biochemical characterization of aqueous and methanolic extract of Triphala, a conventional herbal remedy. Biotechnol Rep (Amst) 2018; 17: 126-36.
[http://dx.doi.org/10.1016/j.btre.2018.02.003] [PMID: 29619331]
[30]
King RJ. Minerals explained 37: Cinnabar. Geol Today 2002; 18(5): 195-9.
[http://dx.doi.org/10.1046/j.0266-6979.2003.00366.x]
[31]
Liu J, Wei LX, Wang Q, et al. A review of cinnabar (HgS) and/or realgar (As4S4)-containing traditional medicines. J Ethnopharmacol 2018; 210: 340-50.
[http://dx.doi.org/10.1016/j.jep.2017.08.037] [PMID: 28864167]
[32]
Prasad SK, Kumar R, Patel DK, Sahu AN, Hemalatha S. Physicochemical standardization and evaluation of in-vitro antioxidant activity of Aconitum heterophyllum Wall. Asian Pac J Trop Biomed 2012; 2(2): S526-31.
[http://dx.doi.org/10.1016/S2221-1691(12)60266-4]
[33]
Singh R, Jawaid T. Cinnamomum camphora (Kapur). Pharmacogn J 2012; 4(28): 1-5.
[http://dx.doi.org/10.5530/pj.2012.28.1]
[34]
Khan KH. Roles of Emblica officinalis in medicine-A review. Bot Res Int 2009; 2(4): 218-28.
[35]
He Q, Ma J, Kalavagunta PK, et al. HgS inhibits oxidative stress caused by hypoxia through regulation of 5-HT metabolism pathway. Int J Mol Sci 2019; 20(6): 1364.
[http://dx.doi.org/10.3390/ijms20061364] [PMID: 30889910]
[36]
Ma HH, Ding YN, Wang A, et al. Cinnabar protects serum-nutrient starvation induced apoptosis by improving intracellular oxidative stress and inhibiting the expression of CHOP and PERK. Biochem Biophys Rep 2021; 27: 101055.
[http://dx.doi.org/10.1016/j.bbrep.2021.101055] [PMID: 34258395]
[37]
Tsoi B, Chen X, Gao C, et al. Neuroprotective effects and hepatorenal toxicity of angong niuhuang wan against ischemia-reperfusion brain injury in rats. Front Pharmacol 2019; 10: 593.
[http://dx.doi.org/10.3389/fphar.2019.00593] [PMID: 31191319]
[38]
Chen C, Zhang BB, Hu AL, Li H, Liu J, Zhang F. Protective role of cinnabar and realgar in Hua-Feng-Dan against LPS plus rotenone-induced neurotoxicity and disturbance of gut microbiota in rats. J Ethnopharmacol 2020; 247: 112299.
[http://dx.doi.org/10.1016/j.jep.2019.112299] [PMID: 31606537]
[39]
Gokarn RA, Gokarn S, Patgiri B, Prajapati PK. Antimicrobial study of Shadguna Rasa Sindhura. J Indian Syst Med 2015; 3(3): 136.
[40]
Tie B, Qi W, Chen G. Determination of soluble mercury contents in Chinese traditional patent medicines for children. Zhongguo Zhongyao Zazhi 1990; 15(10): 602-604, 639.
[PMID: 2268396]
[41]
Nyirimigabo E, Xu Y, Li Y, Wang Y, Agyemang K, Zhang Y. A review on phytochemistry, pharmacology and toxicology studies of Aconitum. J Pharm Pharmacol 2015; 67(1): 1-19.
[http://dx.doi.org/10.1111/jphp.12310] [PMID: 25244533]
[42]
Srivastava N, Sharma V, Kamal B, Jadon VS. Aconitum: Need for sustainable exploitation. Int J Green Pharm 2010; pp. 220-8.
[43]
Hanuman JB, Katz A. New lipo norditerpenoid alkaloids from root tubers of Aconitum ferox. J Nat Prod 1994; 57(1): 105-15.
[http://dx.doi.org/10.1021/np50103a015]
[44]
Aslam MS, Ahmad MS. Analgesic and antiinflammatory activity of genus aconitum: A phytochemical and ethnopharmacological review. Recent Adv Biol Med 2016; 2(2016): 923.
[http://dx.doi.org/10.18639/RABM.2016.02.338815]
[45]
Konda VG, Eerike M, Raghuraman LP, Rajamanickam MK. Antioxidant and nephroprotective activities of aconitum heterophyllum root in glycerol induced acute renal failure in rats. J Clin Diagn Res 2016; 10(3): FF01-2.
[http://dx.doi.org/10.7860/JCDR/2016/10798.7388]
[46]
González P, Marín C, Rodríguez-González I, et al. In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum. Int J Antimicrob Agents 2005; 25(2): 136-41.
[http://dx.doi.org/10.1016/j.ijantimicag.2004.08.010] [PMID: 15664483]
[47]
Dzhakhangirov FN, Sultankhodzhaev MN, Tashkhodzhaev B, Salimov BT. Diterpenoid alkaloids as a new class of antiarrhythmic agents. Structure‐activity relationship. Chem Nat Compd 1997; 33(2): 190-202.
[http://dx.doi.org/10.1007/BF02291540]
[48]
Ameri A. The effects of Aconitum alkaloids on the central nervous system. Prog Neurobiol 1998; 56(2): 211-35.
[http://dx.doi.org/10.1016/S0301-0082(98)00037-9] [PMID: 9760702]
[49]
Sahoo S, Swain TR, Dash NC. Study on the pharmacological profile of purified Aconitum ferox extracts in Frog. Int J Res Pharm Biomed Sci 2013; 4: 746-53.
[50]
Shoaib A, Siddiqui HH, Dixit RK, et al. Neuroprotective effects of dried tubers of Aconitum napellus. Plants 2020; 9(3): 356.
[http://dx.doi.org/10.3390/plants9030356] [PMID: 32168878]
[51]
Shoaib A, Salem-Bekhit MM, Siddiqui HH, et al. Antidiabetic activity of standardized dried tubers extract of Aconitum napellus in streptozotocin‐induced diabetic rats. 3 Biotech 2020; 10(2): 56.
[52]
Dhaliya R, Patil S, Netravathi AB. Evaluation of effect of Vatsanabha (Aconitum ferox Wall.) as a Prativisha against cobra venom (NajaNaja) toxicity: An experimental study. Indian J of Ancient Medicine and Yoga 2018; 11(3): 57-65.
[http://dx.doi.org/10.21088/ijamy.0974.6986.11318.3]
[53]
Chelliah Abiya D. Biological activity prediction of an ethno medicinal plant Cinnamomum camphora through bioinformatics. Ethnobotanical Leaflets 2008; 12: 18190.
[54]
Kumar S, Kumari R, Mishra S. Pharmacological properties and their medicinal uses of Cinnamomum: A review. J Pharm Pharmacol 2019; 71(12): 1735-61.
[http://dx.doi.org/10.1111/jphp.13173] [PMID: 31646653]
[55]
Salama A, Mahmoud HA, Kandeil MA, Khalaf MM. Neuroprotective role of camphor against ciprofloxacin induced depression in rats: Modulation of Nrf-2 and TLR4. Immunopharmacol Immunotoxicol 2021; 43(3): 309-18.
[http://dx.doi.org/10.1080/08923973.2021.1905658] [PMID: 34032546]
[56]
Silva-Filho SE, de Souza Silva-Comar FM, Wiirzler LAM, et al. Effect of camphor on the behavior of leukocytes in vitro and in vivo in acute inflammatory response. Trop J Pharm Res 2014; 13(12): 2031-7.
[http://dx.doi.org/10.4314/tjpr.v13i12.13]
[57]
Lee HJ, Hyun EA, Yoon WJ, et al. In vitro anti-inflammatory and anti-oxidative effects of Cinnamomum camphora extracts. J Ethnopharmacol 2006; 103(2): 208-16.
[http://dx.doi.org/10.1016/j.jep.2005.08.009] [PMID: 16182479]
[58]
Hamidpour R, Hamidpour S, Hamidpour M, Shahlari M. Camphor (Cinnamomum camphora), a traditional remedy with the history of treating several diseases. Int J Case Rep Imag 2013; 4(2): 86-9.
[http://dx.doi.org/10.5348/ijcri-2013-02-267-RA-1]
[59]
VogtEisele AK. Weber K., Sherkheli M.A., Vielhaber G., Panten J., Gisselmann G., Hatt H. Monoterpenoid Agonists of TRPV3. Br J Pharmacol 2007; 151: 53040.
[60]
Ghanta VK, Hiramoto NS, Solvason HB, Soong SJ, Hiramoto RN. Conditioning: A new approach to immunotherapy. Cancer Res 1990; 50(14): 4295-9.
[61]
Edris Amr E. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: A review. Phytother Res 2007; 21(4): 308-23.
[62]
Lola W, Vivian B, Itamar R, Reuven O, Shimon S, Isaac G. Herbal flavonoids inhibit the development of autoimmune diabetes in NOD Mice: Proposed mechanisms of action in the example of PADMA 28. Alternat Med Stud 2011; 1(e1): 16.
[63]
Laude EA, Morice AH, Grattan TJ. The antitussive effects of menthol, camphor and cineole in conscious guinea-pigs. Pulm Pharmacol 1994; 7(3): 179-84.
[http://dx.doi.org/10.1006/pulp.1994.1021] [PMID: 7827436]
[64]
Cardullo MA, Gilroy JJ. Inhibition of oxidative metabolism in Escherichia coli by d-camphor and restoration of oxidase activity by quinones. Can J Microbiol 1975; 21(9): 1357-61.
[http://dx.doi.org/10.1139/m75-203] [PMID: 1102072]
[65]
Prakash S, Shelke AU. Role of Triphala in dentistry. J Indian Soc Periodontol 2014; 18(2): 132-5.
[http://dx.doi.org/10.4103/0972-124X.131299] [PMID: 24872616]
[66]
Avula B, Wang YH, Wang M, Shen YH, Khan IA. Simultaneous determination and characterization of tannins and triterpene saponins from the fruits of various species of Terminalia and Phyllantus emblica using a UHPLC-UV-MS method: Application to triphala. Planta Med 2013; 79(2): 181-8.
[http://dx.doi.org/10.1055/s-0032-1328089] [PMID: 23299756]
[67]
Peterson CT, Denniston K, Chopra D. Therapeutic uses of Triphala in Ayurvedic medicine. J Altern Complement Med 2017; 23(8): 607-14.
[http://dx.doi.org/10.1089/acm.2017.0083] [PMID: 28696777]
[68]
Mehta BK, Shitut S, Wankhade H. In vitro antimicrobial efficacy of Triphala. Fitoterapia 1999; 64: 371-2.
[69]
Lwu MW, Duncan AR, Okunji CO. New antimicrobials of plant origin. In: Janick J, Ed. Perspectives on New Crops and New Uses. Alexandria, USA: ASHS Press 1999; pp. 457-62.
[70]
Pujar M, Patil C, Kadam A. Comparison of antimicrobial efficacy of Tripahala, (GTP) Green tea polyphenols and 3% of sodium hypochlorite on Enterococcus faecalis biofilms formed on tooth substrate: In vitro. J Int Oral Health 2011; 3(2): 23-9.
[71]
Nariya MB, Shukla VJ, Ravishankar B, Jain SM. Comparison of gastroprotective effects of Tripahala formulations on stress-induced ulcer in rats. Indian J Pharm Sci 2011; 73(6): 682-7.
[http://dx.doi.org/10.4103/0250-474X.100252] [PMID: 23112406]
[72]
Bajaj N, Tandon S. The effect of Triphala and Chlorhexidine mouthwash on dental plaque, gingival inflammation, and microbial growth. Int J Ayurveda Res 2011; 2(1): 29-36.
[http://dx.doi.org/10.4103/0974-7788.83188] [PMID: 21897640]
[73]
Saravanan S, Srikumar R, Manikandan S, Jeya Parthasarathy N, Sheela Devi R. Hypolipidemic effect of Triphala in experimentally induced hypercholesteremic rats. Yakugaku Zasshi 2007; 127(2): 385-8.
[http://dx.doi.org/10.1248/yakushi.127.385] [PMID: 17268159]
[74]
Srikumar R, Jeya Parthasarathy N, Sheela Devi R. Immunomodulatory activity of Triphala on neutrophil functions. Biol Pharm Bull 2005; 28(8): 1398-403.
[http://dx.doi.org/10.1248/bpb.28.1398] [PMID: 16079482]
[75]
Juss SS. Tripahala –the wonder drug. Ind Med Gaz 1997; 131: 194-6.
[76]
Kolonel LN, Altshuler D, Henderson BE. The multiethnic cohort study: Exploring genes, lifestyle and cancer risk. Nat Rev Cancer 2004; 4(7): 519-27.
[http://dx.doi.org/10.1038/nrc1389] [PMID: 15229477]
[77]
Kulkarni PH. Clinical assessment of the effect of Sookshma Triphala in lipoma. J Ayurvedic Res Pap 1995; 1995: 66-71.
[78]
Singh PK. Mycotoxin elaboration in Triphala and its constituents. Indian Phytopathol 2003; 56: 380-3.
[79]
Tariq M, Hussain SJ, Asif M, Jahan M. Protective effect of fruit extracts of Emblica officinalis (Gaertn). & Terminalia belerica (Roxb.) in experimental myocardial necrosis in rats. Indian J Exp Biol 1977; 15(6): 485-6.
[PMID: 598885]
[80]
Thakur CP, Thakur B, Singh S, Sinha PK, Sinha SK. The Ayurvedic medicines Haritaki, Amala and Bahira reduce cholesterol-induced atherosclerosis in rabbits. Int J Cardiol 1988; 21(2): 167-75.
[http://dx.doi.org/10.1016/0167-5273(88)90219-7] [PMID: 3225068]
[81]
Nariya MB, Shukla VJ, Ravishankar B, Jain SM. Comparison of gastroprotective effects of Triphala formulations on stress-induced ulcer in rats. Indian J Pharm Sci 2011; 73(6): 682-7.
[http://dx.doi.org/10.4103/0250-474X.100252] [PMID: 23112406]
[82]
Sabina EP, Rasool M. An in vivo and in vitro potential of Indian ayurvedic herbal formulation Triphala on experimental gouty arthritis in mice. Vascul Pharmacol 2008; 48(1): 14-20.
[http://dx.doi.org/10.1016/j.vph.2007.11.001] [PMID: 18065272]
[83]
Amala VE, Jeyaraj M, Mary MM. Renal protective efficacy of Terminalia chebula, Terminalia bellirica, Phyllanthus emblica and their formulation as Triphala on Imidacloprid‐induced renal toxicity by histopathological and biochemical parameters. IOSR J Pharm Biol Sci 2017; 12: 69-74.
[84]
Indu K, Lalithakunjamma CR. Hepatoprotective effect of Triphala in aflatoxicosis. J Plant Sci 2011; 4: 1-4.
[85]
Prativadibhayankaram VS, Malhotra S, Pandhi P, Singh A. Anti-diabetic activity of triphala fruit extracts, individually and in combination, in a rat model of insulin resistance. Nat Prod Commun 2008; 3(2): 1934578X0800300230.
[86]
Kumar MS, Kirubanandan S, Sripriya R, Sehgal PK. Triphala incorporated collagen sponge--a smart biomaterial for infected dermal wound healing. J Surg Res 2010; 158(1): 162-70.
[http://dx.doi.org/10.1016/j.jss.2008.07.006] [PMID: 19118845]
[87]
Sato VH, Sungthong B, Nuamnaichati N, Rinthong PO, Mangmool S, Sato H. In vivo and in vitro evidence for the antihyperuricemic, anti-inflammatory and antioxidant effects of a traditional Ayurvedic medicine, Triphala. Nat Prod Commun 2017; 12(10): 1934578X1701201028.
[88]
Kaur S, Arora S, Kaur K, Kumar S. The in vitro antimutagenic activity of Triphala--an Indian herbal drug. Food Chem Toxicol 2002; 40(4): 527-34.
[http://dx.doi.org/10.1016/S0278-6915(01)00101-6] [PMID: 11893411]
[89]
Jagetia GC, Baliga MS, Malagi KJ, Sethukumar Kamath M. The evaluation of the radioprotective effect of Triphala (an ayurvedic rejuvenating drug) in the mice exposed to gamma-radiation. Phytomedicine 2002; 9(2): 99-108.
[http://dx.doi.org/10.1078/0944-7113-00095] [PMID: 11995956]
[90]
Pompimon W, Sombutsiri P, Baison W, et al. Cancer cytotoxic and anti-HIV potential of Triphala herb mixture on from Chae Son, Lampang, Thailand. J Pharm Res Int 2019; 1-9.
[http://dx.doi.org/10.9734/jpri/2019/v30i630285]
[91]
Jagetia GC, Rao SK, Baliga MS, S Babu K. The evaluation of nitric oxide scavenging activity of certain herbal formulations in vitro: A preliminary study. Phytother Res 2004; 18(7): 561-5.
[http://dx.doi.org/10.1002/ptr.1494] [PMID: 15305317]
[92]
Naik GH, Priyadarsini KI, Bhagirathi RG, et al. In vitro antioxidant studies and free radical reactions of Triphala, an ayurvedic formulation and its constituents. Phytother Res 2005; 19(7): 582-6.
[http://dx.doi.org/10.1002/ptr.1515] [PMID: 16161061]
[93]
Vani T, Rajani M, Sarkar S, Shishoo CJ. Antioxidant properties of the ayurvedic formulation Triphala and its constituents. Int J Pharmacogn 1997; 35(5): 313-7.
[http://dx.doi.org/10.1080/09251619708951274]
[94]
Rinki S, Mishra RN. Adaptogenic activity of Triphala megaExt. Int J Res Pharm Biomed Sci 2011; 2(1): 106-9.
[95]
Sandhya T, Lathika KM, Pandey BN, Mishra KP. Potential of traditional ayurvedic formulation, Triphala, as a novel anticancer drug. Cancer Lett 2006; 231(2): 206-14.
[http://dx.doi.org/10.1016/j.canlet.2005.01.035] [PMID: 15899544]
[96]
Wankhede A, Khirodkar S, Gadhe S. Comparative clinical study of Pushkarmula Churna and Pippali Churna in the management of Kaphaj Kasa in children. Journal of Indian System of Medicine 2018; 6(3): 138.
[97]
Bolan S, Kunhikrishnan A, Seshadri B, et al. Sources, distribution, bioavailability, toxicity, and risk assessment of heavy metal(loid)s in complementary medicines. Environ Int 2017; 108: 103-18.
[http://dx.doi.org/10.1016/j.envint.2017.08.005] [PMID: 28843139]
[98]
Zhou X, Wang L, Sun X, et al. Cinnabar is not converted into methylmercury by human intestinal bacteria. J Ethnopharmacol 2011; 135(1): 110-5.
[http://dx.doi.org/10.1016/j.jep.2011.02.032] [PMID: 21382464]
[99]
Regmi P, Ravikrishna S, Bhat S, Hebbar C. Ethno-botanical and toxicological comparison on varieties of Vatsanabha (Aconitum ferox Wall.) available in Nepal. Int J Ayurveda Trad Med 2020; 2(2): 3-9.
[100]
Fu M, Wu M, Qiao Y, Wang Z. Toxicological mechanisms of Aconitum alkaloids. Pharmazie 2006; 61(9): 735-41.
[PMID: 17020146]
[101]
Fujita Y, Terui K, Fujita M, et al. Five cases of aconite poisoning: Toxicokinetics of aconitines. J Anal Toxicol 2007; 31(3): 132-7.
[http://dx.doi.org/10.1093/jat/31.3.132] [PMID: 17579959]
[102]
Panda AK, Debnath SK. Overdose effect of aconite containing Ayurvedic Medicine (‘Mahashankha Vati’). Int J Ayurveda Res 2010; 1(3): 183-6.
[http://dx.doi.org/10.4103/0974-7788.72493] [PMID: 21170213]
[103]
Gibson DE, Moore GP, Pfaff JA. Camphor ingestion. Am J Emerg Med 1989; 7(1): 41-3.
[http://dx.doi.org/10.1016/0735-6757(89)90083-1] [PMID: 2643959]
[104]
Köppel C, Martens F, Schirop T, Ibe K. Hemoperfusion in acute camphor poisoning. Intensive Care Med 1988; 14(4): 431-3.
[http://dx.doi.org/10.1007/BF00262902] [PMID: 3403777]
[105]
Manoguerra AS, Erdman AR, Wax PM, et al. Camphor Poisoning: An evidence-based practice guideline for out-of-hospital management. Clin Toxicol (Phila) 2006; 44(4): 357-70.
[http://dx.doi.org/10.1080/15563650600671696] [PMID: 16809137]
[106]
Leuschner J. Reproductive toxicity studies of D-camphor in rats and rabbits. Arzneimittelforschung 1997; 47(2): 124-8.
[PMID: 9079230]
[107]
Wu D, Xu T, Huang Z, et al. Systematic evaluation of toxicity of aconite based on bibliometric method. Evid Based Complement Alternat Med 2021; 2021: 5514281.
[http://dx.doi.org/10.1155/2021/5514281] [PMID: 34394380]
[108]
Young YH, Chuu JJ, Liu SH, Lin-Shiau SY. Neurotoxic mechanism of cinnabar and mercuric sulfide on the vestibulo-ocular reflex system of guinea pigs. Toxicol Sci 2002; 67(2): 256-63.
[http://dx.doi.org/10.1093/toxsci/67.2.256] [PMID: 12011485]
[109]
Huang CF, Liu SH, Lin-Shiau SY. Neurotoxicological effects of cinnabar (a Chinese mineral medicine, HgS) in mice. Toxicol Appl Pharmacol 2007; 224(2): 192-201.
[http://dx.doi.org/10.1016/j.taap.2007.07.003] [PMID: 17707451]
[110]
Huang Chun-Fa. Exposure to low dose of cinnabar (a naturally occurring mercuric sulfide (HgS)) caused neurotoxicological effects in offspring mice. BioMed Res Int 2012; 2012: 12.
[http://dx.doi.org/10.1155/2012/254582]
[111]
Huang CF, Hsu CJ, Liu SH, Lin-Shiau SY. Ototoxicity induced by cinnabar (a naturally occurring HgS) in mice through oxidative stress and down-regulated Na(+)/K(+)-ATPase activities. Neurotoxicology 2008; 29(3): 386-96.
[http://dx.doi.org/10.1016/j.neuro.2008.01.005] [PMID: 18329716]
[112]
Chuu JJ, Young YH, Liu SH, Lin-Shiau SY. Neurotoxicity of mercury sulfide in the vestibular ocular reflex system of guinea pigs. Naunyn Schmiedebergs Arch Pharmacol 2001; 364(3): 249-58.
[http://dx.doi.org/10.1007/s002100000279] [PMID: 11521168]
[113]
Wang Y, Wang D, Wu J, et al. Cinnabar induces renal inflammation and fibrogenesis in rats. BioMed Res Int 2015; 2015: 280958.
[http://dx.doi.org/10.1155/2015/280958] [PMID: 25734058]
[114]
Liang A, Wang J, Xue B, et al. Study on hepatoxicity and nephrotoxicity of cinnabar in rats. Zhongguo Zhong Yao Za Zhi 2009; 34(3): 312-8.
[115]
Sheng K, Tian Q, Wang H, Zhao QM. Effects of total alkaloids of Aconitum carmichaeli on rat heart function and its mechanism in vitro. Jiyinzuxue Yu Yingyong Shengwuxue 2019; 38(10): 4709-14.
[116]
Sarkar PK, Prajapati PK, Shukla VJ, Ravishankar B. Effect of shodhana treatment on chronic toxicity and recovery of aconite. Toxicol Int 2012; 19(1): 35-41.
[http://dx.doi.org/10.4103/0971-6580.94515] [PMID: 22736901]
[117]
Regmi P, Ravikrishna S, Bhat S, Hebbar C, Jasphin S. Subacute toxicity of vatsanabha (Aconitum ferox, ranunculaceae) collected from different regions of India and Nepal. J Ayurveda 2021; 15(2): 75-83.
[http://dx.doi.org/10.4103/joa.joa_174_20]
[118]
Xiao K, Wang L, Liu Y, et al. Study of aconitine toxicity in rat embryos in vitro. Birth Defects Res B Dev Reprod Toxicol 2007; 80(3): 208-12.
[http://dx.doi.org/10.1002/bdrb.20116] [PMID: 17570135]
[119]
de Inés C, Reina M, Gavín JA, González-Coloma A. In vitro cytotoxicity of norditerpenoid alkaloids. Z Naturforsch C J Biosci 2006; 61(1-2): 11-8.
[http://dx.doi.org/10.1515/znc-2006-1-203] [PMID: 16610210]
[120]
Somade OT, Adeniji KD, Adesina AA, Olurinde OJ. Oral acute toxicity study as well as tissues oxidative stress and histopathological disorders in edible camphor administered rats. Exp Toxicol Pathol 2017; 69(2): 99-108.
[http://dx.doi.org/10.1016/j.etp.2016.12.001] [PMID: 27955803]
[121]
Al-Muswie RT, Alomer DK, Al-Fartosi KG. Toxopathological effects of camphor on some organs of female rats. Iraqi Med J 2017; 1(4): 105-8.
[122]
Shahabi S, Jorsaraei SG, Akbar Moghadamnia A, et al. The effect of camphor on sex hormones levels in rats. Cell J 2014; 16(2): 231-4.
[PMID: 24567939]
[123]
Eweka AO, Adjene JO, Enaibe BU. Histological studies of the teratogenic effects of camphor on the developing kidney of the wistar rats. Ann Biomed Sci 2008; 7(1-2)
[http://dx.doi.org/10.4314/abs.v7i1-2.43229]
[124]
Sikder MM, Hasan MR, Lopa SS, et al. Toxicological studies of an Ayurvedic medicine Karpur Ras used in diarrhoea. Int J Pharm 2015; 5(2): 472-7.
[125]
Grbić G, Ćulić M, Martać L, Soković M, Spasić S, Đoković D. Effect of camphor essential oil on rat cerebral cortex activity as manifested by fractal dimension changes. Arch Biol Sci 2008; 60(4): 547-53.
[http://dx.doi.org/10.2298/ABS0804547G]
[126]
Ajanal M, Nayak S, Prasad BS, Kadam A. Adverse drug reaction and concepts of drug safety in Ayurveda: An overview. J Young Pharm 2013; 5(4): 116-20.
[http://dx.doi.org/10.1016/j.jyp.2013.10.001] [PMID: 24563588]
[127]
Anonymous. Ministry of health and family welfare (Department of Health). Drugs and cosmetics act 1940 with drugs and cosmetics rules. 1945; p. 317.
[128]
Wal P, Wal A, Gupta S, Sharma G, Rai A. Pharmacovigilance of herbal products in India. J Young Pharm 2011; 3(3): 256-8.
[http://dx.doi.org/10.4103/0975-1483.83780] [PMID: 21897669]
[129]
Sharma R, Kabra A, Rao MM, Prajapati PK. Herbal and holistic solutions for neurodegenerative and depressive disorders: Leads from Ayurveda. Curr Pharm Des 2018; 24(22): 2597-608.
[http://dx.doi.org/10.2174/1381612824666180821165741] [PMID: 30147009]
[130]
Sharma R, Kuca K, Nepovimova E, Kabra A, Rao MM, Prajapati PK. Traditional Ayurvedic and herbal remedies for Alzheimer’s disease: From bench to bedside. Expert Rev Neurother 2019; 19(5): 359-74.
[http://dx.doi.org/10.1080/14737175.2019.1596803] [PMID: 30884983]
[131]
Maurya SK, Seth A, Laloo D, Singh NK, Gautam DN, Singh AK. Śodhana: An Ayurvedic process for detoxification and modification of therapeutic activities of poisonous medicinal plants. Anc. Sci. Life 2015; 34(4): 188-97.
[http://dx.doi.org/10.4103/0257-7941.160862] [PMID: 26283803]
[132]
Sarkar PK, Subha PK. Prajapati, Importance of media in Shodhana of Vatsanabha (Aconite). AYU 2018; 29(1): 52-5.
[133]
Deore SL, Moon KV, Khadabadi SS, Deokate UA, Baviskar BA. Evaluation of toxicity of Vatsanabha (Aconitum ferox) before and after Sodhana. J Young Pharm 2013; 5(1): 3-6.
[http://dx.doi.org/10.1016/j.jyp.2013.01.001] [PMID: 24023444]
[134]
Ambujakshi VM. A comparative experimental evaluation of toxicological effects of Shodhita and Ashodhita Hingula in albino rats. Doctoral dissertation. Government Ayurvedic Medical College, Benglore, 2010.
[135]
Surjith R. Comparative pharmaceutico-analytical study of Shodhita Hingula using different media. Doctoral dissertation. Parul University, Gujarat, India, 2014.
[136]
Vaity PC. Comparative XRF study of Hingula purified in two different media. Ayurpub 2018; 3(2): 830-7.
[137]
Savrikar SS, Ravishankar B. Introduction to ‘rasashaastra’-the iatrochemistry of Ayurveda. Afr J Tradit Complement Altern Med 2011; 8(5) (Suppl.): 66-82.
[http://dx.doi.org/10.4314/ajtcam.v8i5S.1] [PMID: 22754059]
[138]
Sharma R, Prajapati PK. Liquid media’s in Bhavana Samskara: A pharmaceutico-therapeutic prospect. J Phytopharm 2015; 4(1): 49-57.
[http://dx.doi.org/10.31254/phyto.2015.4109]
[139]
Jaglan S, Gautam S, Agrawal DS. Bhawana-importance in pharmaceutics of Rasaushadha. J Ayurveda and Integr Med Sci 2016; 1(2): 74-80.
[140]
Sharma R, Bolleddu R, Maji JK, Ruknuddin G, Prajapati PK. In-vitro α-amylase, α-glucosidase inhibitory activities and in-vivo anti-hyperglycemic potential of different dosage forms of Guduchi (Tinospora cordifolia [Willd. Miers) prepared with Ayurvedic Bhavana process. Front Pharmacol 2021; 12: 642300.
[http://dx.doi.org/10.3389/fphar.2021.642300] [PMID: 34040519]
[141]
Sharma R, Prajapati PK. Nanotechnology in medicine: Leads from Ayurveda. J Pharm Bioall Sci 2016; 8: 80-110.
[142]
Sharma R, Amin H. Rasayana therapy: Ayurvedic contribution to improve quality of life. World J Pharmacol Res Tech 2015; 4: 23-33.
[143]
Sharma R, Martins N. Telomeres, DNA damage and ageing: Potential leads from Ayurvedic Rasayana (anti-ageing) drugs. J Clin Med 2020; 9(8): 2544.
[http://dx.doi.org/10.3390/jcm9082544] [PMID: 32781627]
[144]
Sharma R, Martins N, Kuca K, et al. Chyawanprash: A traditional Indian bioactive health supplement. Biomolecules 2019; 9(5): 161.
[http://dx.doi.org/10.3390/biom9050161] [PMID: 31035513]
[145]
Nilesh K. Evaluation of prativisha properties (antidote properties) of tankana (borax) in vatsanabha vishaktata (aconite poisoning). Int Ayurvedic Med J 2015; 3(7): 1991-8.
[146]
Belvadi S. Concept of Prativisha (Antidotes) in Ayurveda. Ayurpub 2019; 4: 1256-62.
[147]
Aara N, Upadhyay P, Godara S, Ansari MA, Kumar A. A review on antidotes WSR to concept of Prativisha in Ayurveda 2020; 9(14): 243-55.
[148]
Sharma R, Prajapati PK. Predictive, preventive and personalized medicine: Leads from Ayurvedic concept of Prakriti (human constitution). Curr Pharmacol Rep 2020; 6(6): 441-50.
[http://dx.doi.org/10.1007/s40495-020-00244-3]
[149]
Biswas S, Bellare J. Ayurvedic processing of α-HgS gives novel physicochemistry and distinct toxicokinetics in zebrafish. Chemosphere 2020; 251: 126295.
[http://dx.doi.org/10.1016/j.chemosphere.2020.126295] [PMID: 32143074]
[150]
Wang Q, Yang X, Zhang B, Yang X, Wang K. Cinnabar is different from mercuric chloride in mercury absorption and influence on the brain serotonin level. Basic Clin Pharmacol Toxicol 2013; 112(6): 412-7.
[http://dx.doi.org/10.1111/bcpt.12045] [PMID: 23302034]
[151]
Sharma R, Galib R, Prajapati PK. Good pharmacovigilance practice: Accountability of Ayurvedic pharmaceutical companies. Anc Sci Life 2017; 36(3): 167-9.
[http://dx.doi.org/10.4103/asl.ASL_10_17] [PMID: 28867862]
[152]
Sharma R, Hazra J, Prajapati PK. Knowledge and awareness of pharmacovigilance among Ayurveda physicians in Himachal Pradesh. Anc Sci Life 2017; 36(4): 234-5.
[http://dx.doi.org/10.4103/asl.ASL_41_17] [PMID: 29269978]
[153]
Sharma R, Amin H. Galib, Prajapati PK. Validation of standard manufacturing procedure of Guḍūcī sattva (aqueous extract of Tinospora cordifolia (Willd.) Miers) and its tablets. Anc Sci Life 2013; 33(1): 27-34.
[http://dx.doi.org/10.4103/0257-7941.134564] [PMID: 25161327]
[154]
Sharma R, Amin H, Galib R, Prajapati PK. Validation of standard manufacturing procedure of Guduchi Ghana [dried aqueous extract of Tinospora cordifolia (Willd.) Miers] and its tablets. Ayurpharm Int J Ayurveda Allied Sci 2013; 2(7): 224-32.

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy